Is Immuron Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Immuron Ltd (IMC.AX) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Immuron Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Immuron Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Immuron Ltd?

Muslim investors may consider investing in Immuron Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Immuron Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Immuron Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Immuron Ltd updated?

The Shariah compliance status of Immuron Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Immuron Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Immuron Ltd?

You can check the latest Shariah compliance status of Immuron Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

IMC.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 05, 2026

Report Source: 2026 2nd Quarter Report

Immuron Ltd. Stock Analysis IMC.AX

Australia Health Care Nano Cap Report: Q2, 2026

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), and IMM-529.

Key Statistics of Immuron Ltd (IMC.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.03AUD0.03

Today's Open

AUD0.03

Volume

1.42M

P/E Ratio (TTM)

52 Week Range

AUD0.03AUD0.10

Market Cap

9.47M

Avg. Volume

75.33K

Dividend Yield

Financial Metrics & Statements of Immuron Ltd (IMC.AX)

FAQ's for Immuron Ltd (IMC.AX)

According to Musaffa’s Shariah screening methodology, Immuron Ltd (IMC.AX) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.